Prediabetes Deserves More Attention: A Review
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Evidence increasingly demonstrates that prediabetes is a toxic state, as well as a risk factor for diabetes, and is associated with pathophysiological changes in several tissues and organs. Unfortunately, use of available evidence-based treatments for prediabetes is low. This review seeks to explain why prediabetes must be viewed and treated as a serious pathological entity in its own right. It offers an overview of the pathophysiology and complications of prediabetes and describes how this condition can be reversed if all treatment avenues are deployed early in its course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“not only because of the association between prediabetes and cardiovascular risk but also because of the opportunity to improve cardiovascular outcomes through appropriate weight management.”
From Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Diabetes Prevention Program (DPP)
The Diabetes Prevention Program (DPP) Research Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2165 · Cited by 1,938
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Unwin, N. C. (2006) · Cited by 1,661
Huang, Y., Cai, X., Mai, W., Li, M., & Hu, Y. (2016) · BMJ · doi:10.1136/bmj.i5953 · Cited by 1,012 · cited 1×
“(26) concluded that IFG, IGT, and prediabetes (by the ADA A1C criterion) are independently associated with an increased risk of composite cardiovascular events, coronary heart disease, stroke, and all-cause mortality.”
BackgroundHuman Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., Chen, Y., & Ji, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071108 · Cited by 946
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Punthakee, Z., Goldenberg, R., & Katz, P. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.003 · Cited by 877
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Goldenberg, R., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.011 · Cited by 611
Aberrant intestinal microbiota in individuals with prediabetes
the IMI-DIRECT consortium, Allin, K. H., Tremaroli, V., Caesar, R., Jensen, B. A. H., Damgaard, M. T. F., Bahl, M. I., Licht, T. R., Hansen, T. H., Nielsen, T., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4550-1 · Cited by 460 · cited 2×
“(65) demonstrated intestinal dysbiosis characterized by depletion of the genus Clostridium and the mucin-degrading bacterium Akkermansia muciniphila.”
BackgroundResultDiabetes Prevention Program Research Group (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02043.x · Cited by 363
Prediabetes and Cardiovascular Disease
Brannick, B., & Dagogo-Jack, S. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.001 · Cited by 293 · cited 5×
“barriers, and increased ECM component interaction with cell surface receptors (5,7).”
BackgroundInfluential
Cited by
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307563 · Cited by 3,236
Yousef, H., Khandoker, A. H., Feng, S. F., Helf, C., & Jelinek, H. F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1173402 · Cited by 76
Worldwide trends in prediabetes from 1985 to 2022: A bibliometric analysis using bibliometrix R-tool
Zhao, J., & Li, M. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1072521 · Cited by 69
Atherosclerosis and Insulin Resistance: Is There a Link Between Them?
Brie, A. D., Christodorescu, R., Popescu, R., Adam, O., Tîrziu, A., & Brie, D. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061291 · Cited by 58
Cao, Z., Li, W., Wen, C. P., Li, S., Chen, C., Jia, Q., Li, W., Zhang, W., Tu, H., & Wu, X. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4989 · Cited by 40
Metadata
- Authors
- Lawal, Y., Bello, F., & Kaoje, Y. S.
- Affiliations
- Federal Medical Centre (NG)
- Ahmadu Bello University Teaching Hospital (NG)
- Corresponding author
- Lawal, Yakubu
- ORCID
- Lawal, Yakubu
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-10-01
- Volume
- 38
- Issue
- 4
- Pages
- 328-338
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- PMC
- PMC7566925
- OpenAlex
- W3026718593
- Cited by
- 61
- References
- 88
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 17 · 2023: 7 · 2022: 5
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Clinical Diabetes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prediabetes, pathophysiology, diabetes risk, complications, treatment, early intervention, evidence-based treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediabetes Deserves More Attention: A Review. https://app.cochat.ai/papers/10.2337/cd19-0101
- The paper
- Lawal, Y., Bello, F., & Kaoje, Y. S. (2020). Prediabetes Deserves More Attention: A Review. Clinical Diabetes. https://doi.org/10.2337/cd19-0101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.